We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of ferroptosis in cardio-oncology.
- Authors
Hou, Kai; Liu, Lin; Fang, Zhi-Hui; Zong, Wei-Xing; Sun, Daqiang; Guo, Zhigang; Cao, Lu
- Abstract
With the rapid development of new generations of antitumor therapies, the average survival time of cancer patients is expected to be continuously prolonged. However, these therapies often lead to cardiotoxicity, resulting in a growing number of tumor survivors with cardiovascular disease. Therefore, a new interdisciplinary subspecialty called "cardio-oncology" has emerged, aiming to detect and treat cardiovascular diseases associated with tumors and antitumor therapies. Recent studies have highlighted the role of ferroptosis in both cardiovascular and neoplastic diseases. The balance between intracellular oxidative stress and antioxidant defense is crucial in regulating ferroptosis. Tumor cells can evade ferroptosis by upregulating multiple antioxidant defense pathways, while many antitumor therapies rely on downregulating antioxidant defense and promoting ferroptosis in cancer cells. Unfortunately, these ferroptosis-inducing antitumor therapies often lack tissue specificity and can also cause injury to the heart, resulting in ferroptosis-induced cardiotoxicity. A range of cardioprotective agents exert cardioprotective effects by inhibiting ferroptosis. However, these cardioprotective agents might diminish the efficacy of antitumor treatment due to their antiferroptotic effects. Most current research on ferroptosis only focuses on either tumor treatment or heart protection but rarely considers both in concert. Therefore, further research is needed to study how to protect the heart during antitumor therapies by regulating ferroptosis. In this review, we summarized the role of ferroptosis in the treatment of neoplastic diseases and cardiovascular diseases and also attempted to propose further research directions for ferroptosis in the field of cardio-oncology.
- Subjects
CARDIO-oncology; CARDIOTONIC agents; THERAPEUTICS; CARDIOVASCULAR diseases; HEART tumors; MYOCARDIAL reperfusion
- Publication
Archives of Toxicology, 2024, Vol 98, Issue 3, p709
- ISSN
0340-5761
- Publication type
Article
- DOI
10.1007/s00204-023-03665-3